JP2020528274A5 - - Google Patents

Download PDF

Info

Publication number
JP2020528274A5
JP2020528274A5 JP2020502711A JP2020502711A JP2020528274A5 JP 2020528274 A5 JP2020528274 A5 JP 2020528274A5 JP 2020502711 A JP2020502711 A JP 2020502711A JP 2020502711 A JP2020502711 A JP 2020502711A JP 2020528274 A5 JP2020528274 A5 JP 2020528274A5
Authority
JP
Japan
Prior art keywords
splicing variants
subject
expression level
nr4a1
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020502711A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020528274A (ja
JP7223741B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/042712 external-priority patent/WO2019018540A1/en
Publication of JP2020528274A publication Critical patent/JP2020528274A/ja
Publication of JP2020528274A5 publication Critical patent/JP2020528274A5/ja
Application granted granted Critical
Publication of JP7223741B2 publication Critical patent/JP7223741B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020502711A 2017-07-21 2018-07-18 形質細胞疾患の検出方法 Active JP7223741B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762535419P 2017-07-21 2017-07-21
US62/535,419 2017-07-21
PCT/US2018/042712 WO2019018540A1 (en) 2017-07-21 2018-07-18 METHODS FOR DETECTION OF PLASMOCYTE DYSGLOBULINEMIA

Publications (3)

Publication Number Publication Date
JP2020528274A JP2020528274A (ja) 2020-09-24
JP2020528274A5 true JP2020528274A5 (https=) 2021-08-26
JP7223741B2 JP7223741B2 (ja) 2023-02-16

Family

ID=63244986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020502711A Active JP7223741B2 (ja) 2017-07-21 2018-07-18 形質細胞疾患の検出方法

Country Status (13)

Country Link
US (2) US20190025311A1 (https=)
EP (1) EP3655553B1 (https=)
JP (1) JP7223741B2 (https=)
KR (1) KR102785072B1 (https=)
CN (1) CN111194356B (https=)
AU (1) AU2018304242B2 (https=)
BR (1) BR112020000791A2 (https=)
DK (1) DK3655553T3 (https=)
ES (1) ES2916450T3 (https=)
IL (1) IL271465B2 (https=)
MX (1) MX2020000785A (https=)
PL (1) PL3655553T3 (https=)
WO (1) WO2019018540A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3655553B1 (en) 2017-07-21 2022-03-23 Liquid Biopsy Research LLC Methods for detection of plasma cell dyscrasia
MX2022004372A (es) 2019-10-10 2022-07-27 Liquid Biopsy Res Llc Composiciones, métodos y kits para la estabilización de muestras biológicas y de arn.
CN111349705A (zh) * 2020-03-18 2020-06-30 昆明医科大学 circASXL1作为肺癌诊断标志物及其运用
CA3180572A1 (en) * 2020-05-29 2021-12-02 Johan Skog Use of microvesicle signature for the diagnosis and treatment of kidney transplant rejection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005512557A (ja) * 2001-11-07 2005-05-12 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ アーカンソー 遺伝子発現プロファイリングに基づく多発性骨髄腫の診断、予後、および治療標的候補の同定
JP2004313167A (ja) * 2003-02-24 2004-11-11 Joji Inasawa 薬剤耐性マーカーおよびその利用
DK2537942T3 (en) * 2004-05-21 2015-12-14 Trustees Of The University Of Arkansas System Board Of Use of genudtryksprofilering to predict survival in cancer patients
CA2611728A1 (en) 2005-06-08 2006-12-14 Millennium Pharmaceuticals, Inc. Methods for the identification, assessment, and treatment of patients with cancer therapy
JP2012514460A (ja) * 2009-01-02 2012-06-28 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ アーカンソー ボルテゾミブを用いた多発性骨髄腫患者における生存率の予測
WO2011152884A2 (en) 2010-06-04 2011-12-08 Board Of Trustees Of The University Of Arkansas 14 gene signature distinguishes between multiple myeloma subtypes
WO2013155048A1 (en) 2012-04-10 2013-10-17 University Of Utah Research Foundation Compositions and methods for diagnosing and classifying multiple myeloma
EP3655553B1 (en) 2017-07-21 2022-03-23 Liquid Biopsy Research LLC Methods for detection of plasma cell dyscrasia

Similar Documents

Publication Publication Date Title
CN108138222B (zh) 表观遗传染色体相互作用
US20200407791A1 (en) Tissue molecular signatures of kidney transplant rejections
US12258633B2 (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
JP6408380B2 (ja) 癌を患うリスクのある被検体を診断するための方法およびキット
CN105102636B (zh) 用于检测和测定前列腺癌预后的组合物和方法
CA2957396A1 (en) Method of determining pik3ca mutational status in a sample
US20160194709A1 (en) DIAGNOSTIC METHOD FOR PREDICTING RESPONSE TO TNFalpha INHIBITOR
JP2020528274A5 (https=)
US11814683B2 (en) Methods and compositions for predicting chronic lung allograft dysfunction
AU2015279621B2 (en) Methods for diagnosing risk of renal allograft fibrosis and rejection
JP2018524972A (ja) 肺癌の診断または検出のための方法及び組成物
Wu et al. Plasma microRNA signature of patients with IgA nephropathy
CN116287220B (zh) 用于快速诊断川崎病的分子生物标志物和分析方法
JP2021514624A5 (https=)
US20210010090A1 (en) Method and system for predicting recurrence and non-recurrence of melanoma using sentinel lymph node biomarkers
JP2025506444A (ja) 微小残存病変の分析を使用した癌のモニタリングのためのシステムおよび方法
EP3825417A2 (en) Tissue molecular signatures of kidney transplant rejections
CN111194356B (zh) 用于检测浆细胞恶病质的方法
CN108315410B (zh) 一组评估早期流产风险的dna甲基化标志物、引物及其应用
WO2014197936A1 (en) Biomarkers and use thereof in identification of b-cell lymphoproliferative disorders
WO2018160880A1 (en) Compositions and methods for detecting sessile serrated adenomas/polyps
US11421277B2 (en) Methods and compositions for predicting chronic lung allograft dysfunction
CN110656169B (zh) 心房颤动的诊断标志物
CN111315897B (zh) 用于黑素瘤检测的方法
JP2020524524A5 (https=)